Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.217
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.695
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.151
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.324
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.513
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:616m
|
|
|
NotProcessed |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0145
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.348
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
10f:30m
|
|
|
NotProcessed |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00565
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.485
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.821
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00224
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00564
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0451
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000173
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0403
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.237
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.145
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.456
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.459
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.260
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.332
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000695
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0320
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.368
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.490
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.909
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.494
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.893
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0513
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.168
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.842
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0188
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.353
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.541
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0109
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.486
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000629
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.238
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.769
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.918
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.623
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.822
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.995
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00620
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.249
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.728
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00123
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.144
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.482
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:616m
|
|
|
NotProcessed |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0120
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0366
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.726
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00136
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.420
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.433
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0452
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.362
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.485
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0542
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00608
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0170
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.332
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.275
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.640
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.728
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.228
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.373
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
8f:8m
|
|
|
NotProcessed |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00374
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0690
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.649
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
4f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.715
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:40m
|
|
|
NotProcessed |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000777
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.428
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
2f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.893
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0140
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.191
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.726
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.653
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.815
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.945
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.459
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.587
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.597
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:616m
|
|
|
NotProcessed |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0539
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.199
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.492
|
Successful |
Lta4hem3(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0167
|
Successful |
Lta4htm1b(KOMP)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.667
|
Successful |
Lta4hem2(IMPC)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
4f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.723
|
Successful |